Skip to content
GenoLensGenoLens

FGF3

Chr 11q13.3

fibroblast growth factor 3

Aliases:
HBGF-3
MANE:
ENST00000334134.4

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Deafness and congenital structural abnormalities

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Monogenic hearing loss

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Rare syndromic craniosynostosis or isolated multisuture synostosis

Disease associations (Open Targets)

  • deafness with labyrinthine aplasia, microtia, and microdontia

    0.79
  • cancer

    0.59
  • bone development disease

    0.57
  • female reproductive endometrioid cancer

    0.46
  • ovarian carcinoma

    0.37
  • hearing loss disorder

    0.37
  • Hearing impairment

    0.33
  • breast adenocarcinoma

    0.23
  • alcohol drinking

    0.19
  • hereditary disease

    0.19

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Fibroblast growth factor 3

Plays an important role in the regulation of embryonic development, cell proliferation, and cell differentiation. Required for normal ear development

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.